“…Interestingly, and although AGK was not yet described as a component of the TIM22 complex, decreased levels of Adenine nucleotide transporter 1 (a metabolite carrier) were reported for Sengers syndrome patients [ 101 , 190 ]. Additional studies in patients presenting with various forms of this syndrome, identified already described or new mutations in the AGK gene (p.M1I, p.K327*, p.I175Yfs*2, c.424-1G>A, p.R137*, p.I346Yfs*39, p.L75Qfs*12, p.R281*, p.Q291*, c.877+3G>T, p.Q291*, p.F406Vfs*4) [ 102 , 103 , 104 , 105 ]. Two independent studies characterized AGK as a component of the TIM22 complex and showed that this lipid kinase was required for proper metabolite carrier import into the inner membrane [ 167 , 168 ].…”